Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and 5,6,7,8-tetrahydrofolic acid

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with 5,6,7,8-tetrahydrofolic acid in 1 studies

Compound Research Comparison

Studies
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Trials
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Recent Studies (post-2010)
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Studies
(5,6,7,8-tetrahydrofolic acid)
Trials
(5,6,7,8-tetrahydrofolic acid)
Recent Studies (post-2010) (5,6,7,8-tetrahydrofolic acid)
31932124353995

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akao, T; Hattori, M; Jin, JS; Kakiuchi, N; Nakamura, N; Zhao, YF1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and 5,6,7,8-tetrahydrofolic acid

ArticleYear
Isolation and characterization of a human intestinal bacterium, Eubacterium sp. ARC-2, capable of demethylating arctigenin, in the essential metabolic process to enterolactone.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:5

    Topics: 4-Butyrolactone; Adenosine Triphosphate; Biotransformation; Eubacterium; Feces; Furans; Humans; Intestines; Lignans; Molecular Structure; Phylogeny; RNA, Bacterial; RNA, Ribosomal, 16S; Tetrahydrofolates; Time Factors

2007